ferric oxyhydroxide · Vifor Fresenius · NDA 205109
Velphoro
Earliest generic entry, as listed
26 May 2035
Blocked by patent: US 10624855, US 11234938, US 11446252.
Listed patents · 22 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10624855 | — | 26 May 2035 |
| US 11234938 | — | 26 May 2035 |
| US 11446252 | — | 26 May 2035 |
| US 10624855 | product | 26 Nov 2034 |
| US 11234938 | product | 26 Nov 2034 |
| US 11446252 | product | 26 Nov 2034 |
| US 9561251 | — | 23 Jul 2030 |
| US 9561251 | product, use U-1468 | 23 Jan 2030 |
| US 10682376 | — | 13 May 2029 |
| US 10695367 | — | 13 May 2029 |
| US 10925896 | — | 13 May 2029 |
| US 10925897 | — | 13 May 2029 |
| US 10933090 | — | 13 May 2029 |
| US 11013761 | — | 13 May 2029 |
| US 11013762 | — | 13 May 2029 |
| US 10682376 | product | 13 Nov 2028 |
| US 10695367 | product | 13 Nov 2028 |
| US 10925896 | product | 13 Nov 2028 |
| US 10925897 | product | 13 Nov 2028 |
| US 10933090 | product | 13 Nov 2028 |
| US 11013761 | product | 13 Nov 2028 |
| US 11013762 | product | 13 Nov 2028 |
Exclusivities · 2 unexpired
| PED | pediatric (6 months added) | 1 Jan 2028 |
| NPP | new patient population | 1 Jul 2027 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 205109 · 001 · RLD | tablet, chewable, oral | EQ 500MG IRON | 26 May 2035 |